Sign in

CIK 0001022079

  • Large accelerated filer

QUEST DIAGNOSTICS INC

Sign in to watch
Ticker
DGX
Exchange
NYSE
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
161387862
Phone
+1 973-520-2700
Business address
500 PLAZA DRIVE, SECAUCUS, NJ, 07094
Former names
CORNING CLINICAL LABORATORIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,794,069
in 6 filings, $19.8M under 10b5-1 plans

Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-03-10 RUSCKOWSKI STEPHEN H Chairman, CEO and President Shares withheld for taxes −13,898 $106.46 $1.5M 237,747
2020-03-10 RUSCKOWSKI STEPHEN H Chairman, CEO and President Exercise or conversion +100 $71.17 $7K 237,847
2020-03-10 RUSCKOWSKI STEPHEN H Chairman, CEO and President Sale −100 $112.19 $11K 237,747
2020-03-10 RUSCKOWSKI STEPHEN H Chairman, CEO and President Exercise or conversion · Non-Qualifed Stock Option (right to buy) −100 $71.17 $7K 11,717
2020-03-10 DEPPE MICHAEL J VP, Corp. Controller & CAO Grant or award +837 $106.46 $89K 25,253
2020-03-10 DEPPE MICHAEL J VP, Corp. Controller & CAO Shares withheld for taxes −277 $106.46 $29K 24,977
2020-03-10 EGLINTON MANNER CARRIE SVP, Advanced Diagnostics Grant or award +5,018 $106.46 $534K 29,907
2020-03-10 EGLINTON MANNER CARRIE SVP, Advanced Diagnostics Shares withheld for taxes −2,517 $106.46 $268K 27,390
2020-03-06 RUSCKOWSKI STEPHEN H Chairman, CEO and President Exercise or conversion +230,178 $71.17 $16.4M 456,738
2020-03-06 RUSCKOWSKI STEPHEN H Chairman, CEO and President Sale −171,025 $112.21 $19.2M 285,713
2020-03-06 RUSCKOWSKI STEPHEN H Chairman, CEO and President Sale −36,790 $113.65 $4.2M 248,923
2020-03-06 RUSCKOWSKI STEPHEN H Chairman, CEO and President Sale −16,426 $114.24 $1.9M 232,497
2020-03-06 RUSCKOWSKI STEPHEN H Chairman, CEO and President Sale −3,937 $115.45 $455K 228,560
2020-03-06 RUSCKOWSKI STEPHEN H Chairman, CEO and President Sale −2,000 $116.27 $233K 226,560
2020-03-06 RUSCKOWSKI STEPHEN H Chairman, CEO and President Exercise or conversion · Non-Qualifed Stock Option (right to buy) −230,178 $71.17 $16.4M 11,817
2020-02-27 PREVOZNIK MICHAEL E SVP & General Counsel Sale −690 $109.02 $75K 40,087
2020-02-27 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Sale −789 $109.02 $86K 68,411
2020-02-27 Davis J. E. EVP, General Diagnostics Sale −1,100 $109.02 $120K 38,105
2020-02-26 PREVOZNIK MICHAEL E SVP & General Counsel Sale −321 $111.09 $36K 41,445
2020-02-26 PREVOZNIK MICHAEL E SVP & General Counsel Shares withheld for taxes −668 $112.90 $75K 40,777

Page 43 of 52 · 1,040 trades